Naoko Sato Selected Research

Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)

1/2013	Submicroscopic deletion involving the fibroblast growth factor receptor 1 gene in a patient with combined pituitary hormone deficiency.
4/2006	Kallmann syndrome: somatic and germline mutations of the fibroblast growth factor receptor 1 gene in a mother and the son.
8/2005	Gonadotrophin therapy in Kallmann syndrome caused by heterozygous mutations of the gene for fibroblast growth factor receptor 1: report of three families: case report.
3/2004	Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoko Sato Research Topics

Disease

12	Neoplasms (Cancer) 12/2020 - 02/2003
6	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2023 - 01/2022
5	Kallmann Syndrome (Kallmann's Syndrome) 01/2023 - 03/2004
5	Pain (Aches) 01/2023 - 01/2016
4	Inflammation (Inflammations) 04/2024 - 03/2003
4	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2023 - 12/2004
4	Leukemia 09/2019 - 06/2003
3	Carcinoma (Carcinomatosis) 01/2019 - 07/2007
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2016 - 01/2012
2	Hypersensitivity (Allergy) 09/2023 - 06/2011
2	Low Back Pain (Lumbago) 01/2023 - 01/2023
2	Autism Spectrum Disorder 01/2023 - 01/2022
2	Infertility (Sterility) 01/2023 - 04/2015
2	Chronic Pain 01/2023 - 01/2023
2	Deglutition Disorders (Dysphagia) 10/2022 - 01/2022
2	Pituitary Dwarfism 02/2022 - 02/2010
2	Mouth Neoplasms (Oral Cancer) 01/2022 - 10/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2020
2	Hypercholesterolemia 10/2021 - 01/2020
2	Infections 02/2020 - 02/2017
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018 - 01/2017
2	Glioma (Gliomas) 01/2018 - 11/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 03/2003
2	Brain Ischemia (Cerebral Ischemia) 01/2018 - 01/2017
2	Ischemia 01/2018 - 01/2017
2	Endometrial Neoplasms (Endometrial Cancer) 11/2014 - 01/2007
2	Combined Pituitary Hormone Deficiency 01/2013 - 02/2010
2	Neoplasm Metastasis (Metastasis) 07/2010 - 09/2009
2	Anophthalmos (Anophthalmia) 10/2008 - 02/2007
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2007 - 06/2003
2	Ovarian Epithelial Carcinoma 07/2007 - 02/2003
1	Sleep Deprivation 08/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2023
1	Sleep Wake Disorders 08/2023
1	Facial Pain (Myofacial Pain) 06/2023
1	Back Pain (Backache) 01/2023
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Cysts 01/2023
1	Cystic Fibrosis (Mucoviscidosis) 01/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2023
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Hemorrhage 01/2023

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2003
4	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2023 - 01/2022
4	Corticotropin-Releasing HormoneIBA 01/2016 - 01/2012
4	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2013 - 03/2004
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2023 - 12/2004
3	EnzymesIBA 01/2018 - 12/2004
3	Messenger RNA (mRNA)IBA 07/2007 - 01/2007
2	Dopamine (Intropin)FDA LinkGeneric 06/2023 - 01/2023
2	Aripiprazole (Abilify)FDA Link 06/2023 - 01/2023
2	Methylphenidate (Ritalin)FDA LinkGeneric 06/2023 - 01/2023
2	Growth Hormone (Somatotropin)IBA 02/2022 - 10/2008
2	pitavastatin (itavastatin)FDA Link 10/2021 - 01/2020
2	Atorvastatin (Lipitor)FDA Link 10/2021 - 01/2020
2	LipidsIBA 10/2021 - 01/2011
2	AntibodiesIBA 06/2020 - 07/2007
2	Biomarkers (Surrogate Marker)IBA 09/2018 - 11/2016
2	AntioxidantsIBA 01/2018 - 01/2017
2	Inositol (Myoinositol)IBA 01/2018 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2017
2	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 01/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2006
2	Triglycerides (Triacylglycerol)IBA 04/2016 - 01/2011
2	SteroidsIBA 03/2016 - 12/2004
2	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 01/2016 - 01/2012
2	GonadotropinsIBA 04/2015 - 12/2004
2	Testosterone (Sustanon)FDA Link 04/2015 - 12/2004
2	AutoantibodiesIBA 01/2015 - 08/2011
2	Insulin (Novolin)FDA Link 01/2015 - 10/2008
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 07/2010 - 09/2009
2	AntigensIBA 07/2007 - 07/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2007 - 01/2007
2	Gallium-67IBA 12/2004 - 03/2003
1	Calcitonin Gene-Related PeptideIBA 04/2024
1	PolyphenolsIBA 09/2023
1	polybis(carbophenoxypropane) (PCPP)IBA 08/2023
1	Jagged-1 ProteinIBA 01/2023
1	AN 3IBA 01/2023
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	tri-Gly- oxytocinIBA 01/2023
1	threonyl-glycineIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2023
1	Guanfacine (Tenex)FDA LinkGeneric 01/2023
1	Pramipexole (Mirapex)FDA LinkGeneric 01/2023

Therapy/Procedure

12	Therapeutics 06/2020 - 03/2003
4	Drug Therapy (Chemotherapy) 01/2023 - 12/2004
4	Prostheses and Implants (Prosthesis) 01/2022 - 06/2011
3	Radiotherapy 03/2018 - 06/2011
2	Aftercare (After-Treatment) 01/2023 - 03/2018
2	Hematopoietic Stem Cell Transplantation 09/2019 - 07/2010
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2016 - 03/2003
2	Laparotomy 03/2008 - 02/2003
2	Combination Drug Therapy (Combination Chemotherapy) 12/2004 - 03/2003
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2023